IR813-Induced Photothermal Therapy: Leveraging Immunogenic Cell Death for Cancer Treatment DOI Creative Commons
Guangwei Jiang, Rong Huang, Min Qian

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(2), P. 166 - 166

Published: Jan. 26, 2025

Background: Photothermal therapy has the potential to enhance precision and safety of oncological treatments. However, applicable photothermal agents associated with its activated immunogenic cell death remain exploiting. Methods: This study evaluates effectiveness IR813, a agent, combined near-infrared (NIR) light for cancer treatment. In vitro, 4T1 cells were treated IR813 (5 μg/mL) exposed NIR irradiation (1 W/cm2) 5 min. vivo, after tumor-bearing mice administered mg/kg) 10 min, tumor volume, survival immune activation evaluated. Results: significantly increased cytotoxicity following irradiation, resulting in release damage-associated molecular patterns death. Specifically, viability was reduced 5% compared control group. irradiating accumulation at site had mediate substantial suppression, improved mouse survival, metastasis, minimal adverse reactions. Furthermore, responses stimulated by IR813-induced evidenced mature dendritic cytotoxic T lymphocyte counts decrease regulatory spleen, tumor, lymph nodes. Conclusions: These findings suggest that is promising approach enhancing immunotherapy, directly inhibiting tumors while boosting systemic anti-cancer immunity.

Language: Английский

Neutrophil Camouflaged Stealth Nanovehicle for Photothermal‐Induced Tumor Immunotherapy by Triggering Pyroptosis DOI Creative Commons

Xuya Yu,

Guozheng Xing,

Shupei Sheng

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(15)

Published: March 26, 2023

Abstract The regulation of tumor immunosuppressive microenvironments via precise drug delivery is a promising strategy for preventing recurrence and metastasis. Inspired by the stealth strategy, stealthy nanovehicle based on neutrophil camouflage developed to achieve immunotherapy triggering pyroptosis. comprises anti‐CD11b‐ IR820‐conjugated bovine serum albumin nanoparticles loaded with decitabine. Camouflaged neutrophils, nanovehicles efficient hitchhiking owing biotropism neutrophils tumors. fluorescent signal molecule, IR820, acts as navigation monitor track nanovehicle. released decitabine upregulates gasdermin E, laser irradiation activates caspase‐3, thereby resulting in pyroptosis, which improves system's adaptive immune response. In triple‐negative breast cancer animal model, it regulates microenvironment effective induces long‐lasting strong memory prevent lung

Language: Английский

Citations

57

OX40L-expressing M1-like macrophage exosomes for cancer immunotherapy DOI
Yongkang Yu, Tingxuan Li,

Meitong Ou

et al.

Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 365, P. 469 - 479

Published: Dec. 2, 2023

Language: Английский

Citations

55

Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment DOI Creative Commons
Xiujuan Han, Chunai Gong,

Qingru Yang

et al.

International Journal of Nanomedicine, Journal Year: 2024, Volume and Issue: Volume 19, P. 571 - 608

Published: Jan. 1, 2024

Abstract: With the development of nanotechnology, nanoparticles (NPs) have shown broad prospects as drug delivery vehicles. However, they exhibit certain limitations, including low biocompatibility, poor physiological stability, rapid clearance from body, and nonspecific targeting, which hampered their clinical application. Therefore, novel systems with improved biocompatibility high target specificity remains a major challenge. In recent years, biofilm mediated biomimetic nano-drug system (BNDDS) has become research hotspot focus in field life sciences. This new platform uses bio-nanotechnology to encapsulate synthetic NPswithin membrane, organically integrating immunogenicity, toxicity, tumor good adjustability versatility nanocarrier, shows promising applications precision therapy. this review, we systematically summarize progress BNDDS used for optimizing delivery, providing theoretical reference designing safe efficient treatment strategies improve outcomes. Keywords: nanoparticles, cell targeted therapy

Language: Английский

Citations

37

Engineering and Targeting Neutrophils for Cancer Therapy DOI Creative Commons
Jiahui Zhang, Jianmei Gu, Xu Wang

et al.

Advanced Materials, Journal Year: 2024, Volume and Issue: 36(19)

Published: Feb. 7, 2024

Neutrophils are the most abundant white blood cells in circulation and act as first line of defense against infections. Increasing evidence suggests that neutrophils possess heterogeneous phenotypes functional plasticity human health diseases, including cancer. play multifaceted roles cancer development progression, an N1/N2 paradigm is proposed, where N1 exert anti-tumor properties while N2 display tumor-supportive immune-suppressive functions. Selective activation beneficial neutrophil population targeted inhibition or re-polarization tumor-promoting has shown important potential tumor therapy. In addition, due to natural inflammation-responsive physical barrier-crossing abilities, their derivatives (membranes extracellular vesicles (EVs)) regarded advanced drug delivery carriers for enhanced targeting improved therapeutic efficacy. this review, recent advances engineering remodeling microenvironment (TME) comprehensively presented. This review will provide a broad understanding

Language: Английский

Citations

30

Oxygen‐carrying semiconducting polymer nanoprodrugs induce sono‐pyroptosis for deep‐tissue tumor treatment DOI Creative Commons

Fengshuo Wang,

Yongliang Fan,

Yue Liu

et al.

Exploration, Journal Year: 2024, Volume and Issue: 4(4)

Published: Feb. 19, 2024

Abstract Sonodynamic therapy (SDT) has been explored for cancer therapy, especially deep tumors due to its low tissue penetration restriction. The therapeutic efficacy of SDT is limited the complicated tumor microenvironment. This study reports construction oxygen‐carrying semiconducting polymer nanoprodrugs (OSPN pro ) treatment via combining amplified with pyroptosis. An oxygen carrier perfluorohexane, sonodynamic as sonosensitizer, and reactive species (ROS)‐responsive prodrug are co‐loaded into a nanoparticle system, leading formation these nanoprodrugs. Such OSPN show an effective accumulation in tissues after systemic administration, which they deliver relieve hypoxia microenvironment thus mediate producing ROS under ultrasound (US) irradiation, even when covered 2‐cm chicken breast tissue. In addition, ROS‐responsive prodrugs activated by generated trigger pyroptosis cells. sono‐pyroptosis induces strong antitumor immunity obviously higher level infiltrations effector immune cells tumors. Therefore, ‐based combinational can greatly inhibit growth tissue‐covered suppress metastasis. offers nanoplatform strategy.

Language: Английский

Citations

26

Advances and applications of nanoparticles in cancer therapy DOI Creative Commons

Xianzhou Huang,

Tao He, Xiuqi Liang

et al.

MedComm – Oncology, Journal Year: 2024, Volume and Issue: 3(1)

Published: March 1, 2024

Abstract Rapid growth in nanoparticles (NPs) as delivery systems holds vast promise to promote therapeutic approaches for cancer treatment. Presently, a diverse array of NPs with unique properties have been developed overcome different challenges and achieve sophisticated routes enhancement series therapies. Inspiring advances achieved the field therapy using NPs. In this review, we aim summarize up‐to‐date progression addressing various challenges, expect elicit novel potential opportunities alternatively. We first introduce sorts NP technologies, illustrate their mechanisms, present applications. Then, achievements made by break obstacles delivering cargoes specific sites through particular are highlighted, including long‐circulation, tumor targeting, responsive release, subcellular localization. subsequently retrospect recent research treatments from single therapy, like chemotherapy, combination chemoradiotherapy, integrative therapy. Finally, perspectives impact on oncology discussed. believe review can offer deeper understanding

Language: Английский

Citations

26

Lutetium texaphyrin: A photocatalyst that triggers pyroptosis via biomolecular photoredox catalysis DOI Creative Commons
Yunjie Xu, Calvin V. Chau, Jieun Lee

et al.

Proceedings of the National Academy of Sciences, Journal Year: 2024, Volume and Issue: 121(9)

Published: Feb. 21, 2024

Photon-controlled pyroptosis activation (PhotoPyro) is a promising technique for cancer immunotherapy due to its noninvasive nature, precise control, and ease of operation. Here, we report that biomolecular photoredox catalysis in cells might be an important mechanism underlying PhotoPyro. Our findings reveal the photocatalyst lutetium texaphyrin (

Language: Английский

Citations

17

A Twindrive Precise Delivery System of Platelet-Neutrophil Hybrid Membrane Regulates Macrophage Combined with CD47 Blocking for Postoperative Immunotherapy DOI
Shupei Sheng,

Limin Jin,

Yan Zhang

et al.

ACS Nano, Journal Year: 2024, Volume and Issue: 18(6), P. 4981 - 4992

Published: Jan. 9, 2024

During wound healing after cancer surgery, platelets, neutrophils, and macrophages accumulate at the site induce important pathophysiological features. Utilizing these features, development of targeted delivery systems for postoperative tumor immunotherapy is an strategy. Herein, a twindrive precise system hybrid membrane combined with CD47 blocking developed regulation to immunotherapy. The consists IR820-modified platelet-neutrophil membranes loaded R848 nanoparticles. Based on pathological characteristics platelet aggregation neutrophil tendency caused by inflammatory microenvironment could achieve immune drugs sites. After guided fluorescence imaging, reprogram M2 into M1 macrophages, stimulate dendritic cell maturation as adjuvant, then activate T immunity. polarization blockade together enhanced phagocytosis function which cell-mediated cellular response finally effectively inhibit postsurgical recurrence, metastasis, prolonged survival time. It develops regulatory cell-specific responses features

Language: Английский

Citations

16

BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy DOI

Shiman Lu,

Zhaoqing Shi, Chendi Ding

et al.

Biomaterials, Journal Year: 2025, Volume and Issue: 317, P. 123101 - 123101

Published: Jan. 10, 2025

Language: Английский

Citations

2

Biomimetic Prussian blue nanocomplexes for chemo-photothermal treatment of triple-negative breast cancer by enhancing ICD DOI
Ying Long,

Jialong Fan,

Nizhen Zhou

et al.

Biomaterials, Journal Year: 2023, Volume and Issue: 303, P. 122369 - 122369

Published: Oct. 24, 2023

Language: Английский

Citations

32